Inhibiting the formation of amyloid plaques
(70% of patients with dementia)
(70% of patients with dementia)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception of Alzheimer's disease, the amyloid beta precursor protein (APP) and the beta secretase enzyme (BACE1), follow a different path through the brain cells to meet up. It is during the eventual meeting between protein and enzyme that the basis is laid for the development of the disease. Wim Annaert suggests that "closing off or rerouting the path which beta secretase follows to get to APP may perhaps be used to inhibit the rise of the disease. However, a great deal of additional research will be necessary to confirm whether this discovery can effectively lead to a drug." . Continue to read: sciencedaily.com
Multi-nutrient supplement shows anti inflammatory benefits
A supplement containing a mix of B vitamins, amino acids , and botanical extracts was effective at reducing markers of inflammation, says new research. Read more: nutraingredients-usa.com